| Product NDC: | 10019-953 | 
| Proprietary Name: | MESNA | 
| Non Proprietary Name: | MESNA | 
| Active Ingredient(s): | 100 mg/mL & nbsp; MESNA | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10019-953 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019884 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19881230 | 
| Package NDC: | 10019-953-62 | 
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (10019-953-62) | 
| NDC Code | 10019-953-62 | 
| Proprietary Name | MESNA | 
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (10019-953-62) | 
| Product NDC | 10019-953 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | MESNA | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 19881230 | 
| Marketing Category Name | NDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | MESNA | 
| Strength Number | 100 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Cytoprotective Agent [EPC] |